WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) announced the Business Forum company presentations to take place at the 2010 BIO International Convention. The global event for biotechnology will be held May 3-6 in Chicago, Ill. at McCormick Place.
Company presentations will provide valuable insight to the stories, pipelines, and partnering objectives of participating domestic and international companies in 35 different therapeutic and industry tracks, including leading biotechnology & pharmaceutical companies, oncology, cardiology, CNS/neurology, diagnostics, gene/cell therapy, infectious diseases and immunology.
“Currently, we have more than 130 companies scheduled to present at the BIO Business Forum, more than 40 percent of which are international,” said Alan Eisenberg, Executive Vice President of Emerging Companies & Business Development at BIO. “Given the current economic climate, collaborations from the pharmaceutical and biotechnology sector are more important than ever. These presentations and networking opportunities can lead to future collaborations down the road, resulting in innovations in research, medicines and new technologies.”
In addition to company presentations, BIO Business Forum attendees can schedule one-on-one meetings using BIO One-on-One PartneringTM and discuss potential business opportunities through numerous formal and informal networking opportunities. BIO currently expects more than 14,000 meetings among biotechnology and pharmaceutical companies, academic institutions, and investors from around the world. Many companies, including sanofi pasteur, have initiated partnerships after attending the BIO Business Forum.
“This event is a very important component of sanofi pasteur’s partnering efforts,” said Dr. Allan Jarvis, vice president of corporate development at sanofi pasteur. “This year we expect to be booked solid again in our partnering presentations. We believe that this is a great venue to develop successful partnerships to develop vaccines for global health.”
Opportunities are still available for companies interested in presenting at the Business Forum at the 2010 BIO International Convention. Applications will be accepted until April 12, 2010. To request a presentation slot, visit: http://business-forum.bio.org/bf/2010/presentations/presentationapp.asp.
|
2010 Presenting Companies: |
| 7TM Pharma A/S |
| Aastrom Biosciences Inc. (ASTM) |
| Addex Pharmaceuticals (SIX: ADXN) |
| Adolor Corp. (ADLR) |
| Affectis Pharmaceuticals AG |
| Allon Therapeutics Inc. (TSE: NPC) |
| Altea Therapeutics Corporation |
| Amarin Corp. PLC (AMRN) |
| Amnestix, Inc |
| Amylin Pharmaceuticals (AMLN) |
| AstraZeneca (AZN) |
| Bavarian Nordic A/S (CPH: BAVA) |
| Bayer HealthCare (ETR: BAYN) |
| BioGenes GmbH |
| BiondVax Pharmaceuticals Ltd. (TASE: BNDX) |
| Bionomics Ltd (ASX: BNO) |
| BioRealites |
| BioSante Pharmaceuticals Inc. (BPAX) |
| Biovest International, Inc. (BVTI) |
| Boehringer Ingelheim GmbH |
| BTG PLC (LSE: BGC) |
| Calistoga Pharmaceuticals |
| caprotec bioanalytics GmbH |
| Capstone Therapeutics (CAPS) |
| Cardio3 Biosciences |
| Catalyst Biosciences |
| Cevec Pharmaceuticals GmbH |
| Champions Biotechnology (CSBR) |
| CombinatoRx Inc. (CRXX) |
| Cortex Pharmaceuticals Inc. (CORX) |
| Crown Bioscience Inc. |
| CyDex Pharmaceuticals |
| DBV Technologies |
| Debiopharm SA |
| Diamyd Medical AB (STO: DIAM) |
| DSM Biologics |
| Elan Drug Technologies (ELN) |
| Eli Lilly (LLY) |
| Endocrine Technology, LLC |
| EpiCept Corporation (EPCT) |
| Eurand (EURX) |
| FivePrime Therapeutics, Inc. |
| Foamix Ltd. |
| GangaGen Inc. |
| Genentech |
| Genfit (EPA: ALGFT) |
| Genta Inc. (GETA) |
| GlaxoSmithKline (GSK) |
| GlycoMimetics |
| Glycotope GmbH |
| Golden biotechnology Corp. |
| HanAll Biopharma Co., Ltd. (SEO: 009420) |
| Hanmi Pharm. Co., Ltd. (SEO: 008930) |
| Hematech, Inc. |
| Hemispherx Biopharma, Inc. (HEB) |
| Hydra Biosciences |
| Idera Pharmaceuticals, Inc. (IDRA) |
| Immunovaccine Inc. (CVE: IMV) |
| InflammatoRx Inc. |
| Innovascreen Inc |
| Inovio Biomedical Corp. (INO) |
| Isis Pharmaceuticals (ISIS) |
| KAI Pharmaceuticals |
| KaloBios Pharmaceuticals |
| KMT Hepatech, Inc. |
| Koronis Pharmaceuticals |
| Lexicon Pharmaceuticals, Inc. (LXRX) |
| LG Life Sciences (SEO: 068870) |
| Light Sciences Oncology |
| LigoCyte Pharmaceuticals. |
| Logical Therapeutics, Inc. |
| MacroCure Ltd. |
| MacroGenics |
| MDRNA Inc. (MRNA) |
| Medicago Inc. (MDCGF) |
| MedImmune |
| Merck (MRK) |
| Merck Serono |
| MethylGene Inc. (TSE: MYG) |
| Micromet Inc. (MITI) |
| MolMed S.p.A. (BIT: MLM) |
| Movetis NV (EBR: MOVE) |
| NanGenex Inc. |
| National Institutes of Health |
| NexBio, Inc |
| NovaBay Pharmaceuticals, Inc. (NBY) |
| Novavax Inc. (NVAX) |
| Novo Nordisk (NVO) |
| Nuon Therapeutics, Inc. |
| Nycomed |
| Ohmx Corporation |
| Oxygen Biotherapeutics, Inc. (OXBT) |
| PAION AG (ETR: PA8) |
| ParinGenix |
| PDS Biotechnology Corporation |
| Pluristem Therapeutics, Inc. (PSTI) |
| PolyMedix, Inc. (PYMX) |
| Protalix Biotherapeutics Inc. (PLX) |
| PsychoGenics Inc. |
| PTC Therapeutics |
| QRxPharma Limited (ASX: QRX) |
| Receptos |
| Regado Biosciences, Inc. |
| Roche (RHHBY) |
| RXI Pharmaceuticals Corp. (RXII) |
| sanofi pasteur |
| Shionogi (TYO: 5407) |
| Spectrum Pharmaceuticals Inc. (SPPI) |
| Synergy Pharmaceuticals, Inc. (SGYP) |
| Takeda (TYO: 4502) |
| TenX Biopharma, Inc. |
| Tolerx |
| Transgenomic Inc. (TBIO) |
| Tranzyme Pharma |
| University of Pittsburgh |
| Viralytics Ltd (ASX: VLA) |
| Viventia Biotechnologies, Inc |
| WuXi AppTec, Inc (WX) |
| Xenon Pharmaceuticals Inc. |
| YM BioSciences USA Inc. (YMI) |
| Zeltia S.A. (MCE: ZEL) |
| ZIOPHARM Oncology, Inc. (ZIOP) |
| Partnering for Global Health: |
| Aeras Global TB Vaccine Foundation |
| Bill & Melinda Gates Foundation |
| Commons Capital |
| Drugs for Neglected Diseases initiative |
| Global Alliance for TB Drug Development |
| International AIDS Vaccine Initiative |
| Medicines for Malaria Venture |
| PATH |
| WHO Special Programme for Research and Training in Tropical Diseases (TDR) |
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
Be included in official convention coverage - Tag your convention related content, blog posts, photos and videos with:
BIO International Convention: #bio10
BIO Business Forum: #bio1x1
BIO Exhibitors: #bioex
Follow us on Twitter
Listen to our podcasts
Join us on Facebook
Connect with us on LinkedIn
Participate in our Meet-ups
Visit our YouTube Channel
View our photo albums on Flickr
Upcoming BIO Events
BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA
Partnering for Global Health
May 3, 2010
Chicago, IL
McCormick Place Convention Center
BIO International Convention
May 3-6, 2010
Chicago, IL
McCormick Place Convention Center
2010 BIO Human Resources Conference
May 4-7, 2010
Chicago, IL
World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
Washington, DC
BIO India
September 21 - 22, 2010
Hyderabad, India
BIO’s Livestock Biotechnology Summit
September 28-30, 2010
Sioux Falls, SD
CONTACT:
Biotechnology Industry Organization (BIO)
Tracy Krughoff, 202-312-9274
[email protected]
KEYWORDS: United States North America District of Columbia Illinois
INDUSTRY KEYWORDS: Health Biotechnology Cardiology Genetics Infectious Diseases Medical Devices Oncology Pharmaceutical Other Health Research Science
MEDIA:
| Logo |